Skip to content
OpenCapital
Get started

Biohaven BHVN Milestone payment to be paid upon regulatory achievement

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept bhvn:MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's milestone payment to be paid upon regulatory achievement.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's milestone payment to be paid upon regulatory achievement?
Biohaven (BHVN) reported milestone payment to be paid upon regulatory achievement of $711.6M in Q1 2026.
How has Biohaven's milestone payment to be paid upon regulatory achievement changed year-over-year?
Biohaven's milestone payment to be paid upon regulatory achievement increased by 1.4% year-over-year, from $701.98M to $711.6M.